Abstract
Background: Mucinous cystic neoplasms (MCNs) of the pancreas are rare cystic tumors, primarily within the pancreatic body and tail, with low malignancy potential. The radiologic and pathologic characteristics of the cyst dictate the treatment strategy. For MCNs of 2cm without high-risk stigmata or worrisome features, current guidelines recommend resection in young, otherwise healthy, patients given the need for prolonged surveillance; however, the clinical and economic consequences of distal pancreatectomy, including development of diabetes (DM), are not considered with these recommendations. We therefore conducted a cost-effectiveness analysis to evaluate the benefits and risks of continued surveillance versus operative resection for small MCNs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
